Delayed-start analyses of up to 3.5 years in the phase 3 solanezumab expedition program in mild Alzheimer's disease

Title
Delayed-start analyses of up to 3.5 years in the phase 3 solanezumab expedition program in mild Alzheimer's disease
Authors
Keywords
-
Journal
Alzheimers & Dementia
Volume 11, Issue 7, Pages P262-P263
Publisher
Elsevier BV
Online
2015-12-15
DOI
10.1016/j.jalz.2015.07.338

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started